Home Your basket
• Dermatofibrosarcoma protu...
   Price 10.50 €
• Autologous fat graft for ...
   Price 14.00 €
• Occupational therapy in t...
   Price 8.50 €
• Thyroid tuberculosis asso...
   Price 5.50 €
• Eustachian tube melanoma ...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Otosclerosis among patien...
   Price 10.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Management of peritonsill...
   Price 5.50 €
• Management of cerebellopo...
   Price 10.50 €
• Allergic rhinitis...
   Price 8.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• Auditory screening in neo...
   Price 8.50 €
• Cervical cystic lymphangi...
   Price 5.50 €
• The importance of the sta...
   Price 5.50 €
• Importance of swallowing ...
   Price 10.50 €
• Congenital nasal pyriform...
   Price 5.50 €
• Metastatic melanoma to th...
   Price 5.50 €
• Temporal lift...
   Price 10.50 €
• Benign paroxysmal vertigo...
   Price 8.50 €
• Does indermil glue improv...
   Price 5.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Treatments of hereditary ...
   Price 10.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Fronto-ethmoidal fibrous ...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• A comparative acoustic st...
   Price 5.50 €

Total Order 245.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2014 o

RHINOLOGY

Respiratory epithelial adenomatoid hamartomas and olfactory function


Authors : Nagouas C, Bastier PL, De Gabory L.

Ref. : Rev Laryngol Otol Rhinol. 2014;135,4:191-195.

Article published in english
Downloadable PDF document english



Summary : Introduction: Respiratory epithelial adenomatoid hamar­to­ma can occur alone or associated with several diseases with very different pathological processes. Our hypothesis is that REAH is a non-specific reaction of the nose when olfaction is impaired. Material and method: This is a retrospective study including all patients with HERA operated in an academic ENT department. Data analysis focused on the pre and post-operative olfaction, corti­costeroids consumption, histological results of the polyps, the evolution of the disease allowing a comparison of HERA with or without polyps and comparison of data literature. Results: 28 patients suffered from REAH of which 18 are associated with polyps. Nineteen patients had inflammatory disease with a 9 year interval between initial diagnosis and sur­ge­ry of REAH. Olfactory function was improved after surgery (p < 0.01). The cell content of the polyps showed eosinophilic infiltration in 8 patients which 6 were correlated with inflam­matory disease. Lymphoplasmacytic infiltration was present in 10 patients which 8 were correlated with inflammatory disease. Nasal cortico­steroid consumption decreased after surgery (p < 0.02). The mean follow-up after surgery was 34 ± 43 months. Polyp recur­ren­ce rate was 11% (3 patients), and 0% for REAH. Con­clu­sion: In most cases, olfactory function, cellular infiltration and polyp recurrence rate are not correlated with the pathophysiological inflammatory processes that coincides with REAH. Therefore, the co-existence of nasal polyposis with REAH is probably overesti­ma­ted.


Price : 12.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE